XML 40 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1
SHAREHOLDERS EQUITY (Tables)
3 Months Ended
Dec. 31, 2024
SHAREHOLDERS' EQUITY  
Summary of Warrants Outstanding

Number

    

of Warrants

Exercise Price

2,920,000

$

0.0001

2,920,000

  

  

Employee Share Purchase Plan  
SHAREHOLDERS' EQUITY  
Schedule of Share Based Compensation Expense

For the three months ended

December 31, 

    

2024

    

2023

Research and development expense (recovery)

$

(5,029)

 

$

2,411

General and administrative

 

(691)

 

6,496

$

(5,720)

$

8,907

Weighted Average Assumptions for the Valuation of Stock Options

The Company measures the purchase rights based on their estimated grant date fair value using the Black-Scholes option pricing model and the estimated number of shares that can be purchased. The following weighted average assumptions were used for the valuation of purchase rights:

For the three months ended

December 31, 

2024

    

2023

    

Risk-free interest rate

 

4.62

%  

5.18

%  

Expected life of share purchase rights

 

6 months

 

6 months

 

Expected annualized volatility

 

86.88

%  

63.10

%  

Dividend yield

 

 

 

Stock Options Plan  
SHAREHOLDERS' EQUITY  
Schedule of Share Based Compensation Expense

The Company recognized share-based payments expense for options granted and vesting, net of recoveries on cancellations of unvested options, during the period ended December 31, 2024 and 2023 with allocations to its functional expense as follows:

For the three months ended

December 31, 

2024

    

2023

Research and development expense

$

734,809

 

$

523,830

General and administrative

 

1,972,842

 

270,681

$

2,707,651

 

$

794,511

Weighted Average Assumptions for the Valuation of Stock Options

The following weighted average assumptions were used for the Black-Scholes option-pricing model valuation of stock options granted:

2024

    

2023

Risk-free interest rate

 

%  

4.49

%

Expected life of options

 

years

10.0

years

Expected annualized volatility

 

%  

234.00

%

Dividend yield

 

 

Summary of Stock Option Activity

Stock option transactions are summarized as follows:

    

    

Weighted

Number

Average

of Options

Exercise Price*

 

Balance, September 30, 2024

 

9,212,274

$

5.48

Options expired/forfeited

 

(9,250)

 

4.79

Balance outstanding, December 31, 2024

 

9,203,024

$

5.48

Balance exercisable, December 31, 2024

 

7,157,118

$

4.73

*Options exercisable in Canadian dollars as of December 31, 2024 are translated at current rates to reflect the current weighted average exercise price in U.S. dollars for all outstanding options.
Summary of Stock Option Outstanding

At December 31, 2024, options were outstanding enabling holders to acquire common shares as follows:

    

Weighted average remaining

Exercise price

Number of options

contractual life (years)

$

2.39 - 3.23

3,588,900

4.89

$

3.59 - 3.75

936,667

7.29

$

3.81 - 4.67

922,311

3.72

$

5.99 - 7.00

1,644,896

6.11

$

8.47 - 9.76

1,750,000

8.80

$

13.96

190,000

6.03

$

31.62

50,000

6.42

C$

4.90

105,250

2.63

C$

5.06

15,000

4.11

9,203,024

 

6.02